Neha Mehta Mehta-Shah MD

Physician

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2013 - 2016
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2010 - 2012
Northwestern University The Feinberg School of MedicineClass of 2009

Minimal Residual Disease in Peripheral T-cell Lymphoma Start of enrollment: 2017 Jul 31
Completed
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma Start of enrollment: 2021 Oct 08
SUSPENDED
PHASE2
Roles: Principal Investigator, Contact, Study Chair
Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma Start of enrollment: 2021 Apr 29
ACTIVE_NOT_RECRUITING
PHASE1
Roles: Principal Investigator, Contact
Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome Start of enrollment: 2024 Jan 09
RECRUITING
PHASE1
Roles: Principal Investigator, Contact
Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD) Start of enrollment: 2023 Oct 04
RECRUITING
PHASE1, PHASE2
Roles: Principal Investigator, Contact
Join now to see all

PubMed

8 citations
Alopecia areata after mogamulizumab treatment
Neel S. Raval, Nora A. Alexander, Karlee De Monnin, Christine C. Yokoyama, Neha Mehta-Shah
JAAD Case Reports. 2021-11-01
1 citations
An Update on the Current Genomic Landscape of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Sean Harrop, Neha Mehta-Shah, Criselle D'Souza, Ella R. Thompson, Anand K. Deva
Cancers. 2021-09-30
24 citations
Romidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts
Neha Mehta-Shah, Matthew A. Lunning, Alison J. Moskowitz, Adam M. Boruchov, Jia Ruan
American Journal of Hematology. 2021-07-12

Abstracts/Posters

Characteristics, Treatment Patterns, and Outcomes in Primary Cutaneous Gamma Delta T Cell Lymphoma (PCGDTCL): A Real World Multi-Institutional Analysis of a Rare Malig...
Neha Mehta-Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Dose Optimization of Duvelisib in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma from the Phase 2 Primo Trial: Selection of Regimen for the Dose-Expan...
Neha Mehta-Shah, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Aggressive Non-Hodgkin Lymphomas: It's Getting Personal
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Romidepsin in Combination with Gemcitabine, Oxaliplatin, and Dexamethasone Shows Durable Responses in Aggressive Lymphomas
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Pha...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018